These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation. Kawakami A; Osaka M; Aikawa M; Uematsu S; Akira S; Libby P; Shimokado K; Sacks FM; Yoshida M Circ Res; 2008 Dec; 103(12):1402-9. PubMed ID: 18974386 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Kawakami A; Aikawa M; Libby P; Alcaide P; Luscinskas FW; Sacks FM Circulation; 2006 Feb; 113(5):691-700. PubMed ID: 16461842 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein CIII links dyslipidemia with atherosclerosis. Kawakami A; Yoshida M J Atheroscler Thromb; 2009 Mar; 16(1):6-11. PubMed ID: 19262004 [TBL] [Abstract][Full Text] [Related]
5. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses. Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891 [TBL] [Abstract][Full Text] [Related]
6. The effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upregulation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood. Brekke OL; Waage C; Christiansen D; Fure H; Qu H; Lambris JD; Østerud B; Nielsen EW; Mollnes TE Adv Exp Med Biol; 2013; 735():123-36. PubMed ID: 23402023 [TBL] [Abstract][Full Text] [Related]
7. ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen. Rocha NA; East C; Zhang J; McCullough PA Curr Atheroscler Rep; 2017 Nov; 19(12):62. PubMed ID: 29124482 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Kawakami A; Aikawa M; Alcaide P; Luscinskas FW; Libby P; Sacks FM Circulation; 2006 Aug; 114(7):681-7. PubMed ID: 16894036 [TBL] [Abstract][Full Text] [Related]
9. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia. Kypreos KE Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins. Mendivil CO; Zheng C; Furtado J; Lel J; Sacks FM Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):239-45. PubMed ID: 19910636 [TBL] [Abstract][Full Text] [Related]